IE881815L - Production of proteins in active forms - Google Patents

Production of proteins in active forms

Info

Publication number
IE881815L
IE881815L IE881815A IE181588A IE881815L IE 881815 L IE881815 L IE 881815L IE 881815 A IE881815 A IE 881815A IE 181588 A IE181588 A IE 181588A IE 881815 L IE881815 L IE 881815L
Authority
IE
Ireland
Prior art keywords
proteins
production
active forms
host cells
source
Prior art date
Application number
IE881815A
Other versions
IE66334B1 (en
Inventor
Joseph John Patroni
Malcom Roy Brandon
Original Assignee
Rutland Plastics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rutland Plastics filed Critical Rutland Plastics
Publication of IE881815L publication Critical patent/IE881815L/en
Publication of IE66334B1 publication Critical patent/IE66334B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A method for the recovery of proteins in a solubilized form from host cells including providing a source of host cells incorporating a synthesized or expressed protein; providing a source of at least one cationic surfactant; and treating the host cells with at least one cationic surfactant, in an amount sufficient to effect solubilization of the proteins.
IE181588A 1987-06-15 1988-06-15 Production of proteins in active forms IE66334B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPI247287 1987-06-15

Publications (2)

Publication Number Publication Date
IE881815L true IE881815L (en) 1988-12-15
IE66334B1 IE66334B1 (en) 1995-12-27

Family

ID=3772234

Family Applications (1)

Application Number Title Priority Date Filing Date
IE181588A IE66334B1 (en) 1987-06-15 1988-06-15 Production of proteins in active forms

Country Status (14)

Country Link
US (1) US4992531A (en)
JP (1) JPS6447389A (en)
KR (1) KR0126767B1 (en)
CN (1) CN1032425C (en)
AT (1) ATE114156T1 (en)
AU (1) AU609824B2 (en)
CA (1) CA1305284C (en)
DE (1) DE3852116T2 (en)
DK (1) DK322188A (en)
ES (1) ES2065911T3 (en)
IE (1) IE66334B1 (en)
NO (1) NO882635L (en)
NZ (1) NZ225032A (en)
ZA (1) ZA884212B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
EP0295859B1 (en) * 1987-06-15 1994-11-17 Southern Cross Biotech Pty.Ltd. Production of proteins in active forms
US5102989A (en) * 1991-03-15 1992-04-07 Merck & Co., Inc. Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
JPH0774232B2 (en) * 1992-08-31 1995-08-09 農林水産省食品総合研究所長 Novel method for protein purification using detergents
JP3279362B2 (en) * 1992-10-05 2002-04-30 井上 聰一 Diabetes judgment method and diabetes judgment device
JP3319812B2 (en) * 1993-04-05 2002-09-03 井上 聰一 Rheumatism determination method and rheumatism determination device
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
ATE498409T1 (en) 1998-08-06 2011-03-15 Mountain View Pharmaceuticals PEG-URICASE CONJUGATES AND USE THEREOF
IL152804A0 (en) * 2000-05-16 2003-06-24 Bolder Biotechnology Inc Methods for refolding proteins containing free cysteine residues
WO2004027378A2 (en) 2002-09-20 2004-04-01 Promega Corporation Luminescence-based methods and probes for measuring cytochrome p450 activity
WO2004042003A2 (en) * 2002-11-01 2004-05-21 Promega Corporation Cell lysis compositions, methods of use, apparatus, and kit
DE10309691B4 (en) 2003-02-28 2018-10-04 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Recovery of soluble proteins from the biomass of recombinant microorganisms
US20040180445A1 (en) * 2003-03-12 2004-09-16 Domanico Michael J. Methods and compositions for purification of nucleic acid from a host cell
MX2007012548A (en) 2005-04-11 2008-03-11 Savient Pharmaceuticals Inc A variant form of urate oxidase and use thereof.
SG161247A1 (en) 2005-04-11 2010-05-27 Savient Pharmaceuticals Inc Variant forms of urate oxidase and use thereof
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
EP1883425A1 (en) * 2005-05-23 2008-02-06 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
EP2778234B1 (en) 2005-05-31 2017-09-27 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
JP5033177B2 (en) 2006-04-12 2012-09-26 サビエント ファーマセウティカルズ インク． Purification of proteins with cationic surfactants
WO2008076933A2 (en) * 2006-12-14 2008-06-26 Bolder Biotechnology, Inc. Long acting proteins and peptides and methods of making and using the same
JP5597200B2 (en) * 2008-08-18 2014-10-01 プロメガ コーポレイション Compounds producing luminescence and methods for detecting cytochrome P4503A enzyme
GB0901434D0 (en) * 2009-01-29 2009-03-11 Univ Strathclyde Ballast water treatment system
US9377454B2 (en) 2009-06-25 2016-06-28 Crealta Pharmaceuticals Llc Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
CN102905690B (en) 2010-05-21 2016-03-30 西门子医疗保健诊断公司 Zwitterion reagent
CN102965317A (en) * 2012-11-27 2013-03-13 江南大学 Method for screening taurine strains and method for producing taurine through fermenting strains
US9790537B2 (en) 2014-01-29 2017-10-17 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
US10131898B2 (en) * 2014-07-22 2018-11-20 Bio-Rad Laboratories, Inc. Buffers for use with polymerases
CN116637177A (en) 2016-11-11 2023-08-25 好利恩治疗美国公司 Combination therapy of prednisone and uricase molecule and uses thereof
WO2020160325A1 (en) 2019-01-30 2020-08-06 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
WO2020160322A1 (en) 2019-01-30 2020-08-06 Horizon Pharma Rheumatology Llc Tolerization reduces intolerance to pegloticase and prolongs the urate lowering effect (triple)
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476049A (en) * 1983-09-20 1984-10-09 Hoffmann-La Roche Inc. Method for the extraction of immune interferon
US4677196A (en) * 1985-09-06 1987-06-30 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
AU597924B2 (en) * 1985-12-11 1990-06-14 Natinco Nv Solubilization of protein aggregates
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms

Also Published As

Publication number Publication date
DK322188A (en) 1988-12-17
AU609824B2 (en) 1991-05-09
US4992531A (en) 1991-02-12
NO882635D0 (en) 1988-06-15
DE3852116D1 (en) 1994-12-22
IE66334B1 (en) 1995-12-27
JPS6447389A (en) 1989-02-21
NO882635L (en) 1988-12-19
ATE114156T1 (en) 1994-12-15
DK322188D0 (en) 1988-06-14
ES2065911T3 (en) 1995-03-01
CN1032425C (en) 1996-07-31
KR900000380A (en) 1990-01-30
CA1305284C (en) 1992-07-14
CN88103725A (en) 1988-12-28
DE3852116T2 (en) 1995-03-30
NZ225032A (en) 1991-02-26
ZA884212B (en) 1989-03-29
AU1763288A (en) 1988-12-15
KR0126767B1 (en) 1997-12-29

Similar Documents

Publication Publication Date Title
IE881815L (en) Production of proteins in active forms
MY101204A (en) Solubilization of protein aggregates
AU586897B2 (en) Thrombin preparations
SE8903777L (en) LIPOSOME / DOXORUBICIN, COMPOSITION AND PROCEDURE
IL91901A (en) Production of liposomes with improved stability during drying
EP0283713A3 (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
AU1141288A (en) Production of proteins in active forms
IT8819077A0 (en) PROCESS FOR THE PREPARATION OF 1,2 DIFLUOROETHANE AND 1,1,2TRIFLUOROETHANE.
HU9202435D0 (en) Blood factors produced by a recombinant process, method for expressing said bloode factors and recombinant vaccina viruses utilized in said method
GR3007370T3 (en)
MY103362A (en) Production of proteins in active forms
CA2090701A1 (en) Solubilization of proteins in active forms
EP0315118A3 (en) Dna coding for endothelin and use thereof
ZA857166B (en) Process for the extraction of stable camomile extracts which are rich in active agents
TR200002611T2 (en) Beta-lipotropin and its uses
MY103305A (en) Productions of proteins in active forms
GR3003950T3 (en)
KAUFMAN et al. Protein changes in leaf-sheath pulvini of barley(hordeum) induced by gravistimulation[Abstract Only]
IL77152A0 (en) Expression vectors for protein production in e.coli and their production
ITTO930740A1 (en) METHOD FOR THE PRODUCTION OF TIRELLE AUTOMATICALLY AND ELEMENTARY MACHINE TO PERFORM IT.
IT8421028V0 (en) AGRICULTURAL MACHINE STRUCTURE, IN PARTICULAR TO TREAT ARGINI AND SIMILAR.
HU911112D0 (en) Liquid extraction containing active agents of natural origin, and process for the extraction of of the active agents, and cosmetical preparations with possible medicative effect containing such extraction

Legal Events

Date Code Title Description
MM4A Patent lapsed